prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, RUN DATE: RUN TIME. RUN USER. ACCT # : AGE/SX: ROOM: REG DR: BED: SPEC # : RECD: COLL. TIME IN FORMALIN: hrs. COLD ISCHEMA TIME. mins. CLINICAL INFORMATION: Pre-Op Diagnosis: Left breast cancer. Remarks : Specimen (s) : A. Left breast - green is 12 o'clock. B. Left axilla, level 1 and 2. MICROSCOPIC DIAGNOSIS. A. LEFT BREAST (TOTAL MASTECTOMY) : INVASIVE DUCTAL CARCINOMA, TWO SEPARATE FOCI. COMBINED HISTOLOGIC GRADE 3 OF 3. LARGEST INVASIVE CARCINOMA MEASURES 2.8 CM IN GREATEST DIMENSION. HIGH-GRADE DUCTAL CARCINOMA IN SITU PRESENT. MARGINS UNINVOLVED BY INVASIVE CARCINOMA WITH CLOSEST MARGIN DEEP AT 4 MM. MARGINS UNINVOLVED BY IN SITU CARCINOMA WITH CLOSEST MARGIN DEEP AT 1 MM. SEE COMMENT FOR SYNOPTIC REPORT. B. LEFT - AXILLARY METASTATIC LYMPH CARCINOMA NODES, LEVELS IN ONE 1 OF AND FOUR 2 (DISECTION) LYMPH NODES : Carcenoma COCF ifithating duct. COMMENT( (S). CAP APPROVED SURGICAL PATHOLOGY CANCER CASE SUMMARY: INVASIVE CARCINOMA OF THE BREAST. PROCEDURE. Total mastectomy. LYMPH NODE SAMPLING: Axillary dissection. levels 1 and 2. SPECIMEN LATERALITY: Left. HISTOLOGIC TYPE OF. INVASIVE CARCINOMA. Invasive ductal carcinoma. TUMOR SIZE: Greatest dimension of largest focus of invasion : 2.8 cm. HISTOLOGIC GRADE. NOTTINGHAM HISTOLOGIC SCORE: Glandular/tubular differentiation Score 3. Nuclear pleomorphism: Score 3. Mitotic rate: Score 3. Overall grade: Grade 3. TUMOR FOCALITY: Multiple foci of invasive carcinoma. Number of foci: 2. Sizes of individual foci : 2.8 cm and 1.3 cm. DUCTAL CARCINOMA IN SITU: DCIS is present. RUN DATE. RUN TIME. RUN USER. SPEC #: COMMENT (s). Size of DCIS: Estimated size of DCIS at least 5 cm. Nuclear grade : Grade III. Necrosis: Present. central. MARGINS. Invasive carcinoma : Margins uninvolved by invasive. carcinoma. Distance from closest margin: 4 mm to deep. DCIS: Margins uninvolved by DCIS. Distance from closest margin: 1 mm to deep. LYMPH NODES: Total number of lymph nodes examined 4. Number of lymph nodes with metastasis: 1. Size of largest metastatic deposit: 7 mm. Extranodal extension: Not identified. PATHOLOGIC STAGING: Primary tumor: pT2. Regional lymph nodes: Category: pN1a. Distance metastasis: Not applicable. ANCILLARY STUDIES: PERFORMED ON. Estrogen receptor: Positive (100% of tumor cells with. nuclear positivity). Average intensity of tumor cell nuclei staining strong. Progesterone receptor: Positive (2% of tumor cells with. nuclear positivity). Average intensity of tumor cell nuclei staining: weak. HER2 Immunoperoxidase studies: Positive (Score 3+). GROSS DESCRIPTION: Received fresh for tissue banking labeled with the patient's name and designated "left. breast" is a 1,094 gram. 24.0 x 23.0 x 5.5 cm fibrofatty breast. The breast has an. overlying 22.0 x 8.5 cm portion of tan-white skin. The skin has a central 6.5 x 5.5 cm. areola and 1.5 cm raised nipple. There is a green suture on the skin designating 12. o'clock. An indurated nodule is present beneath the skin surface directly medial to the. nipple and underlying the areola. The skin surface and areola have multiple plaque-like. pigmented papules. The largest papule is superior and lateral at the edge of the areola. This papule is 1.6 x 0.8 cm. No additional scars or lesions are identified on the skin. surface The deep margin is ragged and fatty. The specimen is consistent with a simple. mastectomy specimen. The deep margin is inked blue, and the breast is sectioned to have a diffusely glistening. fatty. cut surface. À medial, 2.3 cm nodular tumor mass is present beneath the skin surface. medial in the described area beneath the areola. The tumor has a focal multinodular. appearance at the periphery. but appears to be one mass grossly The mass is 0.7 cm from. the. skin surface, is 6.0 cm from superior, is 3.0 cm from inferior. is 5.0 cm from medial. and 18. 5 cm from lateral. The tumor is at least 4.5 cm from the deep margin. The tumor. has a central stellate, gritty indurated cut surface, and further sectioning shows the. tumor to range up to 2.8 cm. A section of tumor is sampled for tissue banking The. remainder of the parenchyma is diffusely fatty with scant, delicate white fibrous tissue. No additional tumor-like masses are identified. The delicate white fibrous tissue makes up. between 10-15% of the parenchyma The tumor is most closely associated with the lower. RUN DATE : RUN TIME. RUN USER: SPEC #: GROSS DESCRIPTION: (Continued). inner quadrant . Further sectioning of the lower inner quadrant shows a deeper. separate,. 1.3 x 0.7 x 0.5 cm possible tumor mass. This second described mass is 0.3 cm from the deep. margin and is associated with the lower inner quadrant This separate tumor is 5 cm from. the first described tumor underlying the areola. The second mass is 4.5 cm from superior. 4.0 cm from inferior. 2.8 cm from medial. 20 cm from lateral. Representative sections are. sampled as labeled: A1. nipple entirely submitted. A2. en face section of areola. A3. pigmented skin papule. A4. deep margin associated with first described tumor mass. A5-7. sections of first described tumor mass to include mass to skin. A8-10. separate smaller circumscribed-appearing tumor mass at deep margin. entirely submitted. A11. upper outer quadrant. A12. lower outer quadrant. A13. upper inner quadrant. A14. lower inner quadrant (quadrant most closely associated with both tumor. masses. B. Received in formalin. labeled with the patient's name and "left axilla level 1. and. 2". is. a. 5.0. x 4.0 x 2.5 cm aggregate of yellow adipose. The adipose is trimmed to have four. nodular, fatty lymph nodes. The nodes range from 1.2 cm to 2.5 x 1.9 x 1.1 cm. The fat is. trimmed and the nodes are sectioned to be entirely submitted as labeled: B1. two lymph nodes with one lymph node bisected. B2. one lymph node bisected. B3. the largest lymph node bisected. PHOTO DOCUMENTATION. (signature on file).

expanded version (tokens=2087) : 
 The breast pathology report mentions the following:

- Histological classification: The left breast showed invasive ductal carcinoma, with two separate foci, one measuring 2.8 cm and another measuring 1.3 cm. The combined histologic grade was 3 out of 3, with high-grade ductal carcinoma in situ also present. The left axillary lymph nodes showed metastatic carcinoma with ductal features. The overall subtype is LumB.
- Necrosis: There was central necrosis present in the DCIS.
- Tumor infiltrating lymphocytes: There is no mention of tumor-infiltrating lymphocytes in the report.
- Histological grade: The nuclear pleomorphism, glandular/tubular differentiation, and mitotic rate were all scored as 3, resulting in an overall histological grade of 3.
- Receptor status: The estrogen receptor was positive, with 100% of tumor cells showing nuclear positivity. The progesterone receptor was weakly positive, with 2% of tumor cells showing nuclear positivity. HER2 immunoperoxidase studies were positive with a score of 3+.
- Ancillary testing: IHC testing was performed to determine receptor status and HER2 status.
- Lymphovascular invasion: No mention of lymphovascular invasion was made in the report.
- Calcifications: No mention of calcifications was made in the report.
- Other ancillary testing: No other ancillary testing was mentioned in the report.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2258) : 
 Report shows that the left breast suffered from invasive ductal carcinoma, sub-type LumB. Ductal carcinoma in situ was also noted. There was metastatic carcinoma with ductal features in the left axillary lymph nodes. Nuclear grade was 3, and histological grade was 3 out of 3. Receptor status revealed estrogen receptor positive (100%), progesterone receptor weakly positive (2%) and HER2 IHC positive (score 3+). No mention of lymphovascular invasion or calcifications was made. Ancillary testing included IHC testing for receptor status and HER2 status.

